Key Custom and Syndicated Research Products
PRESS RELEASES
Nov. 5, 2008 — A look at the key drivers of prescribing among physicians treating patients with osteoporosis reveals that drugs such as Evista, with its concomitant indication for post-menopausal women at risk for breast cancer, and just-launched yearly Reclast, which boasts the convenience of less-frequent dosing, are the brands expected to lead the market, according to new research by GfK Market Measures.
more >>TELECONFERENCE EVENTS
October 29, 2008 - Sales Force Effectiveness: Beyond the Vital Signs and Into the Hearts and Minds of Your Physician Stakeholders.
more >>PUBLISHED ARTICLES
November 2008 -
Medical Marketing & Media - "Sales Force Report 2008." Which pharma company earned the coveted spot for having the most effective sales force this year? How do current rankings compare with last year? These questions are answered as part of the cover story on pharmaceutical sales forces in Medical Marketing & Media’s November issue, where GfK Market Measures reveals the results of its industry benchmark 2008 sales force effectiveness study.
more >>CONFERENCE EVENTS
May 18-20, 2008 - Pharmaceutical Business Intelligence & Research Group (PBIRG) Annual General Meeting, Washington, DC:
The Research and Politics of Medicare Part D: Is it Working?, Sue Ramspacher, Senior Vice President, GfK Market Measures.
more >>